Search

Juanita Dionne Jackson

Examiner (ID: 392)

Most Active Art Unit
2853
Art Unit(s)
2853, 2108
Total Applications
2176
Issued Applications
2044
Pending Applications
21
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5974388 [patent_doc_number] => 20110152898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'TISSUE ENGINEERED CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 12/991643 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15171 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152898.pdf [firstpage_image] =>[orig_patent_app_number] => 12991643 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/991643
TISSUE ENGINEERED CONSTRUCTS May 7, 2009 Abandoned
Array ( [id] => 6367480 [patent_doc_number] => 20100074849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'ORGANIC ACID FREE EFFERVESCENT FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/425458 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2469 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074849.pdf [firstpage_image] =>[orig_patent_app_number] => 12425458 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/425458
Organic acid free effervescent formulation Apr 16, 2009 Issued
Array ( [id] => 5952610 [patent_doc_number] => 20110033536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => '24-HOUR SUSTAINED-RELEASE METOCLOPRAMIDE' [patent_app_type] => utility [patent_app_number] => 12/935187 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3198 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033536.pdf [firstpage_image] =>[orig_patent_app_number] => 12935187 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/935187
24-HOUR SUSTAINED-RELEASE METOCLOPRAMIDE Mar 26, 2009 Abandoned
12/381399 Method and composition for employing an electrolyzed saline solution exhibiting putative mechanism of action for cancer therapy Mar 10, 2009 Abandoned
Array ( [id] => 6007140 [patent_doc_number] => 20110059171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES' [patent_app_type] => utility [patent_app_number] => 12/921317 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5499 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059171.pdf [firstpage_image] =>[orig_patent_app_number] => 12921317 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921317
ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES Mar 3, 2009 Abandoned
Array ( [id] => 8227203 [patent_doc_number] => 20120141392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/203674 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40863 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203674 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/203674
METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR Feb 26, 2009 Abandoned
Array ( [id] => 5538639 [patent_doc_number] => 20090220444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Antiperspirant and Deodorant Compositions with Improved Protective Action' [patent_app_type] => utility [patent_app_number] => 12/394558 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19843 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220444.pdf [firstpage_image] =>[orig_patent_app_number] => 12394558 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/394558
Antiperspirant and Deodorant Compositions with Improved Protective Action Feb 26, 2009 Abandoned
Array ( [id] => 5532966 [patent_doc_number] => 20090232754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'ENHANCED PHOTOSTABILITY OF SUNCARE COMPOSITIONS CONTAINING AVOBENZONE' [patent_app_type] => utility [patent_app_number] => 12/392465 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5338 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232754.pdf [firstpage_image] =>[orig_patent_app_number] => 12392465 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/392465
ENHANCED PHOTOSTABILITY OF SUNCARE COMPOSITIONS CONTAINING AVOBENZONE Feb 24, 2009 Abandoned
Array ( [id] => 6466564 [patent_doc_number] => 20100040557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Double-layered zaleplon- contained tablet' [patent_app_type] => utility [patent_app_number] => 12/379314 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3664 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040557.pdf [firstpage_image] =>[orig_patent_app_number] => 12379314 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/379314
Double-layered zaleplon- contained tablet Feb 18, 2009 Abandoned
Array ( [id] => 5538813 [patent_doc_number] => 20090220618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING POLYANIONIC MATERIALS AND SOURCE OF HYDROGEN PEROXIDE' [patent_app_type] => utility [patent_app_number] => 12/370706 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11662 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220618.pdf [firstpage_image] =>[orig_patent_app_number] => 12370706 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/370706
PHARMACEUTICAL FORMULATIONS COMPRISING POLYANIONIC MATERIALS AND SOURCE OF HYDROGEN PEROXIDE Feb 12, 2009 Abandoned
Array ( [id] => 6443301 [patent_doc_number] => 20100104727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Methods For Preserving Endogenous TGF-Beta' [patent_app_type] => utility [patent_app_number] => 12/370374 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12828 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104727.pdf [firstpage_image] =>[orig_patent_app_number] => 12370374 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/370374
Methods for preserving endogenous TGF-β Feb 11, 2009 Issued
Array ( [id] => 6517948 [patent_doc_number] => 20100202985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'SUNSCREEN COMPOSITIONS INCLUDING PARTICULATE SUNSCREEN ACTIVES THAT EXHIBIT BOOSTING OF SUN PROTECTION FACTOR' [patent_app_type] => utility [patent_app_number] => 12/369514 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4126 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20100202985.pdf [firstpage_image] =>[orig_patent_app_number] => 12369514 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/369514
SUNSCREEN COMPOSITIONS INCLUDING PARTICULATE SUNSCREEN ACTIVES THAT EXHIBIT BOOSTING OF SUN PROTECTION FACTOR Feb 10, 2009 Abandoned
Array ( [id] => 6579638 [patent_doc_number] => 20100290992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NANOPARTICLE NUCLEIC ACID BINDING COMPOUND CONJUGATES FORMING I-MOTIFS' [patent_app_type] => utility [patent_app_number] => 12/367827 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17552 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0290/20100290992.pdf [firstpage_image] =>[orig_patent_app_number] => 12367827 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/367827
NANOPARTICLE NUCLEIC ACID BINDING COMPOUND CONJUGATES FORMING I-MOTIFS Feb 8, 2009 Abandoned
Array ( [id] => 5952511 [patent_doc_number] => 20110033506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'COMBINATION DOSAGE FORM OF LOW-DOSE MODAFINIL AND LOW-DOSE SILDENAFIL' [patent_app_type] => utility [patent_app_number] => 12/865727 [patent_app_country] => US [patent_app_date] => 2009-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10236 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033506.pdf [firstpage_image] =>[orig_patent_app_number] => 12865727 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865727
COMBINATION DOSAGE FORM OF LOW-DOSE MODAFINIL AND LOW-DOSE SILDENAFIL Feb 7, 2009 Abandoned
Array ( [id] => 5928981 [patent_doc_number] => 20110038940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PULVERULENT COMPOSITION AND A PROCESS FOR PREPARING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/865927 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8741 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038940.pdf [firstpage_image] =>[orig_patent_app_number] => 12865927 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865927
PULVERULENT COMPOSITION AND A PROCESS FOR PREPARING THE SAME Feb 5, 2009 Abandoned
Array ( [id] => 5526756 [patent_doc_number] => 20090196833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'COMPOSITIONS COMPRISING TOPICAL DPD INHIBITORS AND METHODS OF USING SAME IN THE TREATMENT OF HAND-FOOT SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/367367 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10579 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196833.pdf [firstpage_image] =>[orig_patent_app_number] => 12367367 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/367367
COMPOSITIONS COMPRISING TOPICAL DPD INHIBITORS AND METHODS OF USING SAME IN THE TREATMENT OF HAND-FOOT SYNDROME Feb 5, 2009 Abandoned
Array ( [id] => 6321132 [patent_doc_number] => 20100196514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'CALCIUM SILICATE-BASED COMPOSITE CEMENT AND METHODS FOR THE PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/364278 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6602 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196514.pdf [firstpage_image] =>[orig_patent_app_number] => 12364278 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/364278
CALCIUM SILICATE-BASED COMPOSITE CEMENT AND METHODS FOR THE PREPARATION Feb 1, 2009 Abandoned
Array ( [id] => 6195601 [patent_doc_number] => 20110027356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Combination of Oral Medicaments Bonded by a Wrapping' [patent_app_type] => utility [patent_app_number] => 12/864397 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7075 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027356.pdf [firstpage_image] =>[orig_patent_app_number] => 12864397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/864397
Combination of Oral Medicaments Bonded by a Wrapping Jan 25, 2009 Abandoned
Array ( [id] => 6600170 [patent_doc_number] => 20100322864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'TELEMETRY THROUGH REMOTE DETECTION OF NMR-ACTIVE PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/812069 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8830 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322864.pdf [firstpage_image] =>[orig_patent_app_number] => 12812069 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/812069
TELEMETRY THROUGH REMOTE DETECTION OF NMR-ACTIVE PARTICLES Jan 8, 2009 Abandoned
Array ( [id] => 9059406 [patent_doc_number] => 08545841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Methods and compositions for the treatment of cancers and pathogenic infections' [patent_app_type] => utility [patent_app_number] => 12/811646 [patent_app_country] => US [patent_app_date] => 2009-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 4172 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811646 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811646
Methods and compositions for the treatment of cancers and pathogenic infections Jan 4, 2009 Issued
Menu